Inhaled 2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.12, 2005-01, pp. : 1595-1610

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Safety of 2-Adrenoceptor Agonist Use in Patients with Obstructive Airway Disease: A Systematic Review

By Salpeter S.R.

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 405-414

Adis International

Access to resources Recommend Favorite

Is Combination Therapy with Inhaled Anticholinergics and β 2 -Adrenoceptor Agonists Justified for Chronic Obstructive Pulmonary Disease?

By Reddy Chakravarthy B. Kanner Richard E.

Drugs & Aging, Vol. 24, Iss. 8, 2007-01 ,pp. : 615-628

Adis International

Access to resources Recommend Favorite

Use of β-Adrenoceptor Antagonists in Older Patients with Chronic Obstructive Pulmonary Disease and Cardiovascular Co-Morbidity: Safety Issues

By Andrus Miranda R. Loyed Joyce V.

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 131-144

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Inhaled Long-Acting β 2 -Agonists in the Management of Obstructive Pulmonary Disease

By Sovani Milind P. Whale Christopher I. Tattersfield Anne. E.

Drug Safety, Vol. 27, Iss. 10, 2004-01 ,pp. : 689-715

Adis International

Access to resources Recommend Favorite

-adrenoceptor agonists increase cardiovascular risk

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite